Denis M. Callewaert
Fondateur chez Oxford Biomedical Research, Inc.
Profil
Denis M.
Callewaert is the founder of Oxford Biomedical Research, Inc. founded in 1984.
He also worked as the Chief Scientific Officer at Zivo Bioscience, Inc. Additionally, he holds a doctorate degree from Oakland University (Michigan).
Postes actifs de Denis M. Callewaert
| Sociétés | Poste | Début |
|---|---|---|
Oxford Biomedical Research, Inc.
 Oxford Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company's primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. OBR is employing proprietary technology to develop tissue and disease specific biomarkers. ProteoMine™ is a cost effective tool for removing high abundance proteins for biomarker discovery. ToxProfiler™ technology captures and detects oxidized proteins in blood correlated with organ-specific toxicity and disease. New platform technologies such as Toxic proteomics and Metabolomics are being applied, adapted and modified into new and practical ways for the diagnosis of early onset disease and for the prevention of diseases. The company was founded in 1984 and is headquartered in Rochester Hills, MI. | Fondateur | 17/05/2011 |
Anciens postes connus de Denis M. Callewaert
| Sociétés | Poste | Fin |
|---|---|---|
| ZIVO BIOSCIENCE, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Denis M. Callewaert
| Oakland University (Michigan) | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZIVO BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Oxford Biomedical Research, Inc.
Oxford Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company's primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. OBR is employing proprietary technology to develop tissue and disease specific biomarkers. ProteoMine™ is a cost effective tool for removing high abundance proteins for biomarker discovery. ToxProfiler™ technology captures and detects oxidized proteins in blood correlated with organ-specific toxicity and disease. New platform technologies such as Toxic proteomics and Metabolomics are being applied, adapted and modified into new and practical ways for the diagnosis of early onset disease and for the prevention of diseases. The company was founded in 1984 and is headquartered in Rochester Hills, MI. | Commercial Services |
